---  
layout: startup_page  
title: "Myricx Bio"  
id: "myricxbio.com"  
permalink: "/myricxbiomyricxbio.com07082024/"  
website: "https://myricxbio.com/"  
funding_round: "Series A"  
funding_amount: "$114M"  
investors: "Novo Holdings, Abingworth, British Patient Capital, Eli Lilly & Company, Sofinnova Partners, Brandon Capital"  
about: "Myricx Bio is a UK biotech company developing a novel class of payloads for antibody-drug conjugates (ADCs) based on N-myristoyltransferase inhibitors (NMTis). These ADCs target cancer cell survival, addressing unmet needs in oncology with demonstrated preclinical efficacy and safety. The company is a spinout from Imperial College London and the Francis Crick Institute."  
markets: "Biotechnology, Oncology, Pharmaceuticals, Life Science, Therapeutics"  
hq: "London, England, United Kingdom"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/myricx-bio"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/myricx-pharma"  
pitchbook: "https://pitchbook.com/profiles/company/453377-71"  

date_display: "08-Jul-2024"  
date: "2024-07-08"

# SEO Optimization  
meta_title: "Myricx Bio - Series A Funding ($114M)"  
meta_description: "Myricx Bio, Myricx Bio is a UK biotech company developing a novel class of payloads for antibody-drug conjugates (ADCs) based on N-myristoyltransferase inhibitors..."  
meta_keywords: "Myricx Bio, Biotechnology, Oncology, Pharmaceuticals, Life Science, Therapeutics, Series A funding"  
canonical_url: "https://startup.projectstartups.com/myricxbiomyricxbio.com07082024/"  
---